Analyzing glycosylation using the recombinant domain of CD301 (MGL, CLEC10A) revealed, for the first time, the expression of CD301 ligands on osteosarcoma cell lines and primary osteosarcomas. This evidence concerns the gene CLEC10A and osteosarcoma.